Literature DB >> 10099015

Interaction of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae.

R M Ros-Moreno1, M J Moreno-Guzmán, A Jiménez-González, F Rodríguez-Caabeiro.   

Abstract

The value of the gamma-aminobutyric acid (GABA) receptor of nematodes as a target for ivermectin's mode of action remains unclear. Using binding assays, we examined extracts from Trichinella spiralis muscle larvae for the presence of [3H]-ivermectin and [3H]-GABA binding sites. Tissue preparations displayed affinity binding sites for [3H]-ivermectin with a dissociation constant (Kd) of 83 nM and a receptor density (Bmax) of 145 fmol/mg protein. We also identified a specific [3H]-GABA binding activity with a Kd of 1.2 microM and a Bmax of 4.78 pmol/mg protein. In competition studies, ivermectin was found to be a competitive inhibitor of specific [3H]-GABA binding activity with an inhibition constant (K(i)) of 3.39 nM, suggesting that GABA receptors could be implicated in the mechanism of action of ivermectin in nematodes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099015     DOI: 10.1007/s004360050555

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

Review 1.  Nematode cys-loop GABA receptors: biological function, pharmacology and sites of action for anthelmintics.

Authors:  Michael V Accardi; Robin N Beech; Sean G Forrester
Journal:  Invert Neurosci       Date:  2012-03-20

2.  Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice.

Authors:  Dalia A Elmehy; Marwa A Hasby Saad; Gamal M El Maghraby; Mona F Arafa; Nema A Soliman; Heba H Elkaliny; Dina I Elgendy
Journal:  Parasitol Res       Date:  2021-05-04       Impact factor: 2.289

3.  Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra Bhattacharya; F J Ahmad; Mohammad Samim; M Z Abidin; A K Dinda
Journal:  Parasitol Res       Date:  2013-12-24       Impact factor: 2.289

4.  Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep.

Authors:  M B Molento; A Lifschitz; J Sallovitz; C Lanusse; R Prichard
Journal:  Parasitol Res       Date:  2003-11-21       Impact factor: 2.289

Review 5.  Epidemiology, diagnosis, treatment, and control of trichinellosis.

Authors:  Bruno Gottstein; Edoardo Pozio; Karsten Nöckler
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

6.  Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.

Authors:  Maha M A Basyoni; Abdel-Aleem A El-Sabaa
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.